173 related articles for article (PubMed ID: 6971309)
21. Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.
Carter VC; Rice PL; Tevethia SS
Infect Immun; 1982 Jul; 37(1):116-26. PubMed ID: 6286488
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
Nash AA; Phelan J; Wildy P
J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
[TBL] [Abstract][Full Text] [Related]
24. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):208-13. PubMed ID: 3972502
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of T cell-mediated cytolysis by 2-deoxy-D-glucose:dissociation of the inhibitory effect from glycoprotein synthesis.
MacDonald HR; Cerottini JC
Eur J Immunol; 1979 Jun; 9(6):466-70. PubMed ID: 315316
[TBL] [Abstract][Full Text] [Related]
26. Functional cytotoxic T cells are associated with focal lesions in the brains of SJL mice with experimental herpes simplex encephalitis.
Hudson SJ; Streilein JW
J Immunol; 1994 Jun; 152(11):5540-7. PubMed ID: 8189071
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
Banks TA; Jenkins FJ; Kanangat S; Nair S; Dasgupta S; Foster CM; Rouse BT
Virology; 1994 Apr; 200(1):236-45. PubMed ID: 8128625
[TBL] [Abstract][Full Text] [Related]
28. Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2.
Sethi KK; Brandis H
Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):162-73. PubMed ID: 198986
[TBL] [Abstract][Full Text] [Related]
29. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
30. T cell-mediated cytotoxic immune response to HSV infection and its modification due to antimetabolites.
Röllinghoff M; Pfizenmaier K; Falke D; Wagner H
Adv Ophthalmol; 1979; 38():247-54. PubMed ID: 316643
[No Abstract] [Full Text] [Related]
31. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
33. Natural killer (NK) cells prevent virus production in cell culture.
Baraz L; Khazanov E; Condiotti R; Kotler M; Nagler A
Bone Marrow Transplant; 1999 Jul; 24(2):179-89. PubMed ID: 10455347
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
35. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
36. Reduced antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells of salivary polymorphonuclear leukocytes and inhibition of peripheral blood polymorphonuclear leukocyte cytotoxicity by saliva.
Ashkenazi M; Kohl S
J Immunol; 1990 Jun; 144(12):4781-7. PubMed ID: 1972168
[TBL] [Abstract][Full Text] [Related]
37. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
[TBL] [Abstract][Full Text] [Related]
38. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
39. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
[TBL] [Abstract][Full Text] [Related]
40. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
